Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(NY:
TOVX
)
4.110
-1.790 (-30.34%)
Official Closing Price
Updated: 8:00 PM EDT, Sep 3, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about TOVX
< Previous
1
2
Next >
Why Zhibao Technology Shares Are Trading Higher By Around 19%; Here Are 20 Stocks Moving Premarket
September 03, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 02, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 02, 2024
Via
Benzinga
What's Going On With Theriva Biologics Stock?
August 30, 2024
Theriva Biologics shares are trading higher Friday on continued momentum following a series of catalysts this week. Here's a look at the details:
Via
Benzinga
Peering Into Theriva Biologics's Recent Short Interest
August 20, 2024
Via
Benzinga
What's Going On With Theriva Biologics (TOVX) Stock?
August 19, 2024
Theriva Biologics shares are trading lower by 8.4% Monday morning. The company announced a 1-for-25 reverse stock split.
Via
Benzinga
Preview: Theriva Biologics's Earnings
March 22, 2024
Via
Benzinga
Earnings Outlook For Theriva Biologics
November 10, 2023
Via
Benzinga
Nasdaq Jumps Over 100 Points; Dell Posts Upbeat Results
August 30, 2024
Via
Benzinga
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
August 29, 2024
Via
Benzinga
Theriva Biologics Receives Rare Pediatric Drug Designation From FDA For Treatment Of Retinoblastoma
August 26, 2024
Theriva Biologics Receives Rare Pediatric Drug Designation From FDA For Treatment Of Retinoblastoma
Via
News Direct
Exposures
Product Safety
Nasdaq Surges 150 Points; Sonder Holdings Shares Surge
August 19, 2024
Via
Benzinga
Why Nikola Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
August 19, 2024
Via
Benzinga
Crude Oil Down 2%; Alzamend Neuro Shares Spike Higher
August 19, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Jumps Over 100 Points; Estee Lauder Shares Edge Lower After Q4 Results
August 19, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
TOVX Stock Earnings: Theriva Biologics Beats EPS for Q2 2024
August 13, 2024
TOVX stock results show that Theriva Biologics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers
August 01, 2024
Theriva Biologics Advances Its Product Pipeline To Improve Survival Rates For Many Difficult-To-Treat Cancers
Via
News Direct
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
June 10, 2024
Via
Benzinga
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic Pancreatic Cancer
June 07, 2024
--News Direct--
Via
News Direct
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 05, 2024
Via
Benzinga
TOVX Stock Earnings: Theriva Biologics Beats EPS for Q1 2024
May 07, 2024
TOVX stock results show that Theriva Biologics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Why Hibbett Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
April 23, 2024
Via
Benzinga
Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers
April 17, 2024
Theriva Biologics Hits Several Milestones In 2023, Positioning Itself For Growth As The Firm Targets Difficult-To-Treat Cancers
Via
News Direct
Earnings Scheduled For March 25, 2024
March 25, 2024
Companies Reporting Before The Bell • Bitcoin Depot (NASDAQ:BTM) is expected to report quarterly loss at $0.08 per share on revenue of $161.50 million.
Via
Benzinga
How Theriva Biologics Is Using An Adenovirus To Develop A Novel Treatment For Pancreatic Cancer, As Well As Other Cancers With An Unmet Need
March 14, 2024
--News Direct--
Via
News Direct
Topics
Death
Exposures
Death
Could This Common Virus Unlock New Cancer Treatments? Theriva Biologics Believes That Adenoviruses Could Be Instrumental In The Next Evolution Of Oncology
March 06, 2024
--News Direct--
Via
News Direct
For The First Time The US Is Set To Hit 2 Million New Cancer Cases: Theriva Biologics Presents Novel Solutions To The Deadliest Cancers
February 29, 2024
--News Direct--
Via
News Direct
Topics
Death
Exposures
Death
12 Health Care Stocks Moving In Monday's Intraday Session
December 25, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2023
November 13, 2023
Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.